Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children's hospitals.
Nicolas A BamatHaresh KirpalaniChris FeudtnerErik A JensenMatthew M LaughonHuayan ZhangHeather M MonkMolly PassarellaScott A LorchPublished in: Journal of perinatology : official journal of the California Perinatal Association (2019)
Infants with severe BPD are exposed to alarming number of medications of unclear efficacy and safety, with marked variation between center.